SARS-CoV-2 Transmission From People Without COVID-19 Symptoms | Infectious Diseases | JAMA Network Open | JAMA Network
Covid19-Sources
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study - 2021.01.27.21250517v1.full.pdf
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study | medRxiv
Eurosurveillance | Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020
GitHub & BitBucket HTML Preview
(1) Andrej Reisin auf Twitter: "In Zeiten, in denen #Schulen i.d. Öffentlichkeit weitgehend zu einem Ort kindlicher+jugendlicher Glückseligkeit verklärt werden, möchte ich mit diesem Thread 🔽 daran erinnern, dass diese Vorstellung als "umstritten" gelten kann, gelinde gesagt. 1/15 https://t.co/KtVIXM7GMT https://t.co/34kJFqnJmm" / Twitter
micb25.github.io/dka
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | Science
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers | NEJM
Shane Crotty auf Twitter: "1/ Now for the thornier data." / Twitter
Everyday Covid mistakes we are all still making | Coronavirus | The Guardian
Corona – Virologe Christian Drosten: Deswegen macht die aktuelle Lage Hoffnung
(2) Carl Jakobs auf Twitter: "#COVID19 Skeptiker: Warum ist Grippe eliminiert? Schien mir wg kleinerem R0 der Grippe plausibel, habe deswegen aber Windpocken, Keuchhusten und Mumps in DE für die letzten 3J angeschaut. Sind gedrückt aber nicht weg. Evtl guter Anzeiger für Strenge und Befolgung der Massnahmen! https://t.co/IdPUcrGZ0P" / Twitter
The Coronavirus Has Claimed 2.5 Million Years of Potential Life in the U.S., Study Finds - The New York Times
Wie tödlich ist Covid-19? - MedWatch - der Recherche verschrieben
The Climate Crisis and Covid-19 — A Major Threat to the Pandemic Response | NEJM
Mortality Analyses - Johns Hopkins Coronavirus Resource Center
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques | Nature
Corona: Bis zu 80 Prozent asymptomatische Fälle? - Anteil der infizierten Menschen ohne Symptome scheint stark zu variieren - scinexx.de
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections | Nature Medicine
Inferring the effectiveness of government interventions against COVID-19 | Science
Ranking the effectiveness of worldwide COVID-19 government interventions | Nature Human Behaviour
The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries - The Lancet Infectious Diseases
Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic | Scientific Reports
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study - The Lancet
Chapter 1. How resilient have European health systems been to the COVID-19 crisis? | Health at a Glance: Europe 2020 : State of Health in the EU Cycle | OECD iLibrary
Belgium′s COVID-19 health care collapse: ′It will happen in 10 days′ | Science| In-depth reporting on science and technology | DW | 30.10.2020
How Iceland hammered COVID with science
K: The Overlooked Variable That's Driving the Pandemic - The Atlantic
Precautionary breaks: planned, limited duration circuit breaks to control the prevalence of COVID-19 | medRxiv